This was the stock's fourth consecutive day of losses.

Bristol Myers Squibb won the dismissal of a proposed class action accusing it of fraudulently obtaining patents and filing ...

Fintel reports that on April 8, 2025, Goldman Sachs downgraded their outlook for Bristol-Myers Squibb (NYSE:BMY) from Buy to ...

High-yielding dividend stocks can be great investments to hold on to in your portfolio, but only if they're safe. Betting on ...

Today's Research Daily features new research reports on 16 major stocks, including Exxon Mobil Corporation (XOM), ...

Bristol Myers Squibb (BMY) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at ...

Shares of Bristol Myers Squibb Co. BMY shed 3.32% to $55.30 Friday, on what proved to be an all-around grim trading session ...

Better-than-expected financial results in recent quarters have signaled an improved outlook, helping to sustain the rally.

Bristol-Myers Squibb awarded its CEO nearly $19 million in compensation for 2024, following a challenging year for the ...

Learn more about whether Bristol-Myers Squibb Company or Jazz Pharmaceuticals plc is a better investment based on AAII's A+ ...

Bristol-Myers Squibb (NYSE:BMY – Get Free Report) was the target of a significant growth in short interest during the month ...